JavaScript is disabled in your browser. Please enable JavaScript to view this website.

PCNA

GeneName

PCNA

Summary

PCNA, also known as cyclin or proliferating cell nuclear antigen, is a 29 kDa protein that plays a crucial role in DNA replication and repair. It is primarily localised in the nucleus, where it forms a homotrimeric ring structure that encircles DNA, acting as a processivity factor for DNA polymerase during leading strand synthesis. PCNA is involved in various cellular processes including chromatin organisation, mismatch repair, and base-excision repair. It also interacts with numerous proteins, such as histone acetyltransferases and DNA polymerases, to facilitate its functions in DNA metabolism and cellular responses to DNA damage.

Importance

PCNA is relevant to: - DNA replication and repair mechanisms, making it a target for cancer research and therapeutic interventions - Cellular responses to oxidative stress and DNA damage, which are critical in understanding ageing and disease processes - Regulation of cell cycle progression and differentiation, particularly in rapidly dividing cells such as those in the epithelial and germ cell lineages - Its potential as a biomarker for cell proliferation in various cancers, aiding in diagnosis and treatment strategies

Top Products

For researchers investigating PCNA, we recommend two excellent primary antibodies that cater to a variety of applications. The first is the highly regarded Anti-PCNA antibody [PC10] (ab29), a well-cited monoclonal antibody with 917 citations, demonstrating its reliability in Western blotting (WB), immunohistochemistry (IHC), immunocytochemistry (ICC), and flow cytometry (FC). This antibody has established itself as a trusted tool in the field.Additionally, we offer the recombinant antibody, Anti-PCNA antibody [EPR3821] (ab92552), which has been validated for use in WB, IHC, ICC, flow cytometry (FC), and immunoprecipitation (IP). With 567 citations, this recombinant product provides the batch-to-batch consistency that researchers often seek. Together, these antibodies provide robust options for studying PCNA in various experimental contexts. The Human PCNA ELISA Kit (ab196270), supported by 3 citations, is an excellent option for researchers looking to accurately measure PCNA levels in their samples.

Abcam Product Citation Summary

The data indicates a significant focus on the role of PCNA in various cancer contexts, particularly in human cell lines and tissues. The use of multiple antibodies in Western blotting and immunohistochemistry highlights the importance of PCNA as a marker for cell proliferation and tumor growth. Studies span a range of cancer types, including glioblastoma, cervical cancer, and hepatocellular carcinoma, suggesting that PCNA is a critical target for understanding cancer biology and potential therapeutic interventions.

Abcam Product Citation Table

ab18197
Human
IHC-IF
glioblastoma tumors
26881967
ab18197
Mouse
WB
alveolar macrophages
28198368
ab18197
Human
ICC
human cells
26022740
ab18197
Human
WB
PANC-1 cells
27756327
ab18197
Human
WB
cervical cancer cells
30559605
ab18197
Human
WB
cervical cancer cells
30559605
ab18197
Human
WB
human cells
30459526
ab18197
Human
IHC
hepatocellular carcinoma tissues
31387619
ab18197
Human
IHC
hepatocellular carcinoma
31387619
ab19166
Human
WB
NSCLC cell lines
32147945
ab19166
Human
WB
NSCLC cell lines A549 and NCI-H460
31721438
ab19166
Human
WB
NSCLC cell lines A549 and NCI-H460
31721438
ab19166
Human
WB
SNK-6 cells
32969473
ab19166
Human
WB
SNK-6 cells
32969473
ab19166
Human
WB
SNK-6 cells
32969473
ab19166
Danio rerio
IHC
spinal cords following spinal cord injury
31069223
ab19166
Danio rerio
IHC
spinal cord sections
31069223
ab201673
Human
WB
HCC cells
29497076
ab201673
Human
WB
human cells
29497076
ab29
Human
IHC
lung tissue
27088061
ab29
Mus musculus
WB
skin tissue
28855649
ab29
Human
IHC
tumor tissues from MDA-MB-231 xenograft study
28439094
ab29
Gallus gallus
WB
jejunal and ileal mucosae
31766443
ab29
Rattus norvegicus
IHC
xenograft tumor tissue
32201510
ab29
Human
WB
cervical cancer cells
32201510
ab29
Mus musculus
WB
Mus musculus
32214146
ab29
Rattus norvegicus
WB
astrocytes following spinal cord injury
27807407
ab29
Rattus norvegicus
WB
total prostate protein
27504137
ab29
Rattus norvegicus
IHC
hepatic proliferation and inflammation
32121064
ab29
Human
WB
breast cancer cells
31957232
ab29
Human
WB
MDA-MB-231 cells
31957232
ab29
Caenorhabditis elegans
WB
DNA replication regulation
26842564
ab29
Human
WB
HeLa cells
21858012
ab29
Mus musculus
WB
proliferation of MMCs
34012764
ab29
Mus musculus
WB
adipocytes
29250056
ab29
Human
WB
tumor xenografts
31354888
ab29
Drosophila melanogaster
IHC-IF
ovaries
29751847
ab29
Human
WB
cell lines
28109268
ab29
Human
WB
AGS-Gr cells
28109268
ab92552
Mus musculus
WB
arterial media layer
29354055
ab92552
Human
IHC
tumor samples
32231464
ab92552
Human
WB
melanoma cells
32051829
ab92552
Human
WB
chondrocytes
31820164
ab92552
Human
ICC
hepatocellular carcinoma cells
31969493
ab92552
Human
WB
gastric cancer cells
32190008
ab92552
Human
WB
gastric cancer cells
32190008
ab92552
Human
WB
gastric cancer cells
32190008
ab92552
Human
WB
HepG2.2.15 cells
31880390
ab92552
Human
WB
cervical cancer cells
31889905
ab92552
Human
WB
cervical adenocarcinoma HeLa cells
31889905
ab92552
Rattus norvegicus
WB
fibroblast activation
31949126
ab92552
Rattus norvegicus
WB
NF-κB signaling in chondrocytes
29333456
ab92552
Human
WB
H1299 cells
26599082
ab92552
Human
WB
thyroid cancer cell lines
32157211
ab92552
Human
WB
H1299 cells
26599082
ab92729
Human
WB
HEK293T cells
24098681
ab92729
Human
WB
HEK293T cells
24098681

Function

Confers DNA tethering and processivity to DNA polymerases and other proteins (PubMed:24695737, PubMed:24939902, PubMed:35585232). Auxiliary protein of DNA polymerase delta and epsilon, is involved in the control of DNA replication by increasing the polymerases' processivity during elongation of the leading strand (PubMed:35585232). Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways (PubMed:24939902). Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion (PubMed:24695737).

Involvement in disease

Ataxia-telangiectasia-like disorder 2

ATLD2

A neurodegenerative disorder due to defects in DNA excision repair. ATLD2 is characterized by developmental delay, ataxia, sensorineural hearing loss, short stature, cutaneous and ocular telangiectasia, and photosensitivity.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

Phosphorylated. Phosphorylation at Tyr-211 by EGFR stabilizes chromatin-associated PCNA.

Acetylated by CREBBP and p300/EP300; preferentially acetylated by CREBBP on Lys-80, Lys-13 and Lys-14 and on Lys-77 by p300/EP300 upon loading on chromatin in response to UV irradiation (PubMed:19419956, PubMed:24939902). Lysine acetylation disrupts association with chromatin, hence promoting PCNA ubiquitination and proteasomal degradation in response to UV damage in a CREBBP- and EP300-dependent manner (PubMed:24939902). Acetylation disrupts interaction with NUDT15 and promotes degradation (PubMed:19419956).

Ubiquitinated (PubMed:20227374, PubMed:24939902). Following DNA damage, can be either monoubiquitinated to stimulate direct bypass of DNA lesions by specialized DNA polymerases or polyubiquitinated to promote recombination-dependent DNA synthesis across DNA lesions by template switching mechanisms. Following induction of replication stress, monoubiquitinated by the UBE2B-RAD18 complex on Lys-164, leading to recruit translesion (TLS) polymerases, which are able to synthesize across DNA lesions in a potentially error-prone manner. An error-free pathway also exists and requires non-canonical polyubiquitination on Lys-164 through 'Lys-63' linkage of ubiquitin moieties by the E2 complex UBE2N-UBE2V2 and the E3 ligases, HLTF, RNF8 and SHPRH. This error-free pathway, also known as template switching, employs recombination mechanisms to synthesize across the lesion, using as a template the undamaged, newly synthesized strand of the sister chromatid. Monoubiquitination at Lys-164 also takes place in undamaged proliferating cells, and is mediated by the DCX(DTL) complex, leading to enhance PCNA-dependent translesion DNA synthesis. Sumoylated during S phase.

Methylated on glutamate residues by DCPH1/C6orf211.

Sequence Similarities

Belongs to the PCNA family.

Cellular localization

Alternative names

DNA sliding clamp PCNA, Cyclin, Proliferating cell nuclear antigen, PCNA

swissprot:P12004 omim:176740 entrezGene:5111